Studies Highlight Emerging Treatment Options for Neuroendocrine Tumors

Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) — a rare and hard-to-treat cancer. The first publication focuses on a cancer immunotherapy developed by two of her

Read more

Promising Vaccine Therapy for Glioblastoma Brain Cancers Moves on to Larger, Multisite Study

Phase II clinical trial will assess efficacy of Roswell Park-developed immunotherapy in newly diagnosed patients BUFFALO, N.Y. — An innovative vaccine therapy developed at Roswell Park Cancer Institute (RPCI) is being tested in a multisite clinical trial involving 50 patients with newly diagnosed glioblastoma brain tumors. The

Read more